NOX 1.52% 6.7¢ noxopharm limited

Observations, page-2

  1. 424 Posts.
    lightbulb Created with Sketch. 206
    https://www.6pr.com.au/noxopharm-anti-cancer-patents-granted/

    GK giving a small rundown of who will benefit if CEP-2 works and why I think patient recruitment shouldn’t take too long.

    An update for first patient dosed in DARRT-2 would be very welcome and hopefully not too far away. With these three trials (IONIC) all starting close to one another, positive results will present big pharma with a wealth of supporting data.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.